__timestamp | Alnylam Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
---|---|---|
Wednesday, January 1, 2014 | 190249000 | 1488000000 |
Thursday, January 1, 2015 | 276495000 | 1525000000 |
Friday, January 1, 2016 | 382392000 | 2111000000 |
Sunday, January 1, 2017 | 390635000 | 1848000000 |
Monday, January 1, 2018 | 505420000 | 1213000000 |
Tuesday, January 1, 2019 | 655114000 | 1010000000 |
Wednesday, January 1, 2020 | 654819000 | 997000000 |
Friday, January 1, 2021 | 792156000 | 967000000 |
Saturday, January 1, 2022 | 883015000 | 838000000 |
Sunday, January 1, 2023 | 1004415000 | 953000000 |
Monday, January 1, 2024 | 1126232000 | 998000000 |
Data in motion
In the competitive landscape of pharmaceuticals, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Alnylam Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited have demonstrated contrasting approaches to R&D spending.
From 2014 to 2023, Alnylam's R&D expenses surged by over 400%, reflecting its commitment to pioneering RNA interference therapeutics. In contrast, Teva's R&D spending saw a decline of approximately 36%, indicating a strategic shift towards optimizing existing product lines and cost management.
By 2023, Alnylam's R&D expenses reached a peak, surpassing $1 billion, while Teva's spending stabilized around $950 million. This divergence highlights Alnylam's aggressive pursuit of innovation compared to Teva's more conservative approach. As the pharmaceutical industry evolves, these strategic choices will shape the future trajectories of both companies.
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc
Alnylam Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Insmed Incorporated
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Pharming Group N.V.
Teva Pharmaceutical Industries Limited or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Grifols, S.A.
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Apellis Pharmaceuticals, Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Alkermes plc
Research and Development Investment: Teva Pharmaceutical Industries Limited vs Xenon Pharmaceuticals Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs MiMedx Group, Inc.